LncR-NEAT1 is high expressed in PTX-resistant NSCLC cells and mediates PTX resistance through activation of the Protein kinase B/mammalian target of rapamycin (Akt/mTOR) pathway [205]. Here, AKT1 is linked to non-small cell lung carcinoma.